Quantcast
  • E-mail
  • Print
  • Comment
  • Font Size
  • Digg
  • del.icio.us
  • Discuss article

China Aoxing Pharmaceutical Company to Present at the Red Chip Small-Cap Conference in San Francisco

Posted on: Monday, 21 May 2007, 09:00 CDT

NEW YORK, May 21 /PRNewswire-FirstCall/ -- China Aoxing Pharmaceutical Company, Inc. (BULLETIN BOARD: CAXG) , a pharmaceutical company based in China that specializes in analgesics and pain management products, including Oxycodone, Pholcodine, Naloxone, and Tilidine, today announced that the Company will attend the Red Chip Small-Cap Investor Conference on May 29, 2007 at the Ritz Carlton Hotel in San Francisco, California.

Management is currently scheduled to present at 1:45 pm PT / 4:45 pm ET. Listeners may access a live webcast of the presentation by visiting http://www.redchip.com/. Investors who would like more information about attending the Red Chip Small-Cap Conference should contact Red Chip directly or visit their website at http://www.redchip.com/.

About China Aoxing Pharmaceutical Group

China Aoxing Pharmaceutical Company, Inc. (BULLETIN BOARD: CAXG) is a pharmaceutical company in China specializes in research, development, manufacturing and distribution of a variety of analgesics and pain management products. Its operating subsidiary, Hebei Aoxing Pharmaceutical Group Co. Ltd, is a corporation organized under the laws of the People's Republic of China. Hebei Aoxing is one of only a handful of companies in China to be granted the license to manufacture drugs, including Oxycodone, Pholcodine, Naloxone, Tilidine, and is working closely with the Chinese government to assure their availability throughout China.

Contact: Ashley M. Ammon & Bill Zima Integrated Corporate Relations, Inc. 203 682 8200

China Aoxing Pharmaceutical Company, Inc.

CONTACT: Ashley M. Ammon & Bill Zima, both of Integrated CorporateRelations, Inc., +1-203-682-8200, for China Aoxing Pharmaceutical Company,Inc.

Web site: http://www.redchip.com/


Source: PRNewswire-FirstCall

More News in this Category


Related Articles



Rating: 3.2 / 5 (5 votes)
Rate this article:
1/52/53/54/55/5

User Comments (0)

Comment on this article

Your Name
Text from the image
Comment
max 1200 chars
* All fields are required